September 19, 2006 - ASM Sends Letter to Congressman Barton on NIH Reauthorization

The ASM sent a letter to Congressman Joe Barton on the NIH Reauthorization legislation supporting the proposed increases in NIH funding

September 10, 2002 - NSF FY 2003 Funding for the Biological Sciences Directorate

ASM Thanks Senate Subcommittee for NIH $2 Billion Budget Increase

The ASM sent letters to Senators Roy Blunt and Patty Murray thanking the Senate Labor/HHS Subcommittee for proposing a $2 Billion budget increase for the National Institutes of Health.

November 8, 2002 - Research and Public Health Programs Appropriations for FY 2003

May 24, 2016 - ASM Letter on DOE FY 2017 Appropriations

The ASM sent a letter to all members of the House of Representatives regarding DOE Provisions in House Amendment to S. 2012, the Energy Policy Modernization Act of 2016.

August 23, 2002 - ASM Recommendations on Biodefense Research Funded by the National Institute of Allergy and Infectious Diseases

May 18, 2016 - ASM Supports $1.9 Billion Emergency Funding to Combat Zika

The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.

December 13, 2016 - Listening Session with the FDA Commissioner

Janet Shoemaker and Kimberly Walker from ASM participated in a listening session with FDA Commissioner Robert Califf on rare diseases.

ASM Members Meet with Senate Appropriations Chair

ASM volunteer leaders have on been Capitol Hill advocating for funding for the microbial sciences and their messages have accelerated congressional action on funding to address the Zika threat.

December 2, 2016 - 21st Century Cures Bill Passes House

The 21st Century Cures Act passed the House of Representatives on November 30.  It authorizes $4.8 billion over a ten year period for targeted initiatives at the NIH and $500 million for the FDA.  The bill is expected to be voted on in the Senate the week of December 5.  The Office of Public Affairs has prepared an analysis of the bill's provisions.

May 11, 2016 – ASM Comments on Department of Labor Employee Exemptions Definitions Impact on Research

The ASM sent a letter to Howard A. Shelanski, Ph.D., Administrator, Office of Information and Regulatory Affairs, Office of Management and Budget regarding the impact of the Department of Labor’s “Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees” on research.

November 10, 2016 - ASM and PASCV Comment on Transplant Virus Testing

The ASM and Pan American Society for Clinical Virology (PASCV)  comment on reclassification of tests for the measurement of virus DNA levels in transplant-associated infections.

ASM Acts to Counter Zika Virus Outbreak

A key role of a scientific association is to make the voices of its many individual members heard as a unified whole. Speaking on behalf of its 47,000 members worldwide, ASM has acted quickly to make the case to policy makers that we must take immediate and aggressive action against the emerging threat of Zika virus infection.

October 26, 2016 - ASM Joins PEW, IDSA and BD in Breakpoints Letter to Senate HELP Committee

ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation. 

ASM Celebrates Medical Laboratory Professionals Week

ASM is a supporter of Medical Laboratory Professionals Week (MLPW) April 24-30, 2016 and salutes the more than 300,000 medical laboratory professionals around the country who perform and interpret more than 10 billion laboratory tests in the United States every year.

October 26, 2016 - ASM Joins PEW, IDSA and BD in Breakpoints Letter to Senate HELP Committee

ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation.

April 11, 2016 - Soliciting Stakeholder Input for the BMBL Revision

The ASM sent a bulk e-mail to members soliciting input for the Biosafety in Microbiological and Biomedical Laboratories (BMBL) Revision.

October 17, 2016 - ASM, AMP and PASCV Express Concerns On New Molecular Test for Zika

The ASM, the Association for Molecular Pathology (AMP) and Pan American Society for Clinical Virology (PASCV) ask for data and clarification on the rRT-PCR assay for the testing of Zika, dengue and chikungunya viruses.

April 8, 2016 - ASM Letter on Zika and Emerging Infectious Disease Funding

The ASM sent a letter to Congress regarding emergency funding for the Zika outbreak.  The ASM supports providing new funding to fight public health emergencies.

October 3, 2016 - White Paper on the Emergence of mcr-1 Plasmid-Mediated Colistin Resistance

The Committee on Laboratory Practices has developed a white paper to update members on colistin resistance and testing.

Department of Defense - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

September 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response

The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.

Department of Energy - FY 2017

The ASM submitted funding recommendations to Congress for the Department of Energy for fiscal year 2017.

November 9, 2016 - ASM Recommendations to the Presidential Transition

The ASM sent policy recommendations to strengthen science, technology and public health in the United States.

PSAB Funding Statements from 1997

The content of this page is restricted to ASM Members only.

Please login at the top-right or to become a member, join ASM.

August 30, 2016 - ASM Asks for Clarification on CLIA Personnel Regulations

ASM requests clarification on an April CMS State Survey Agency Directors memorandum regarding personnel policies on individuals performing non-waived tests.

March 14, 2016 - ASM Comments on Select Agents and Toxins Regulations

The ASM sent comments to the Centers for Disease Control and Prevention (CDC) and the Animal and Plant Health Inspection Service (APHIS) regarding the biennial review of the List of Select Agents and Toxins and enhanced biosafety requirements. 

August 29, 2016 - ASM Letter Concerning UN Meeting on Antimicrobial Resistance

ASM sent a letter Samantha Power, the US Ambassador to the United Nations regarding the September 21 meeting of the UN General Assembly on antimicrobial resistance

ASM Funding Recommendations to Congress for Fiscal Year 2017

The ASM has submitted appropriation recommendations to Congress for federal agencies that support biomedical and public health research.

 

ASM Urges Members to Support Petition Calling for United Nations to Collaborate to Combat Antimicrobial Resistance

The American Society for Microbiology will be participating in a September 21 meeting of the United Nations General Assembly to discuss how countries can cooperate to address antimicrobial resistance (AMR).  We urge ASM members to join the petition being circulated by IDSA on Change.org calling for the United Nations to work together to combat antimicrobial resistance in preparation for the meeting to discuss the topic.

U.S. Department of Agriculture - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

ASM Actions on Zika


Zika Funding Update

Zika tnSeptember 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response
The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.

Funding Alert: Contact Congress for Emergency Funding for Zika
The ASM has been working since February to urge congressional passage of a $1.9 billion emergency supplemental funding bill to respond to the Zika virus. The House and Senate passed Zika funding bills, but a conference agreement failed in the Senate over political controversy, stalling congressional passage of a final Zika funding bill before Congress left for the summer recess.  Please click the link above to contact your congressional delegation to urge immediate passage of a bipartisan emergency supplemental bill for Zika.

ASM Acts to Counter Zika Virus Outbreak
A summary of all Zika related ASM activities.

ASM Letters and Statements

August 5, 2016 - ASM Urges Public Health Actions and Funding to Combat Zika Emergency

July 18, 2016 - ASM Urges Congressional Action on Emergency Zika Funding
The ASM sent Majority Leader McConnell and Minority Leader Reid, Speaker Ryan and Minority Leader Pelosi a letter urging action on funding to combat the threat of Zika.

May 18, 2016 - ASM Supports $1.9 Billion Emergency Funding to Combat Zika
The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.

April 8, 2016 - ASM Letter on Zika and Emerging Infectious Disease Funding
The ASM sent a letter to Congress regarding emergency funding for the Zika outbreak.  The ASM supports providing new funding to fight public health emergencies.

February 23, 2016 - ASM Endorses Letter Requesting Additional Funding for Zika
The ASM signed onto a letter sent to Congress supporting the White House request for supplemental funds to prepare for and respond to Zika.

February 12, 2016 - ASM Letter to Congress Regarding Zika Virus
The ASM sent a letter to Congress supporting the President's supplemental budget request of $1.8 billion to prepare and respond to the Zika virus outbreak.

 

 

 

National Science Foundation - FY 2017

The ASM submitted funding recommendations to Congress for the National Science Foundation for fiscal year 2017.

July 27, 2016 - ASM Asks VA for Clarification on Proposed Advance Practice Registered Nurse Duty Changes

ASM comments focus on Advance Practice Nurses ability to perform laboratory testing

Food and Drug Administration - FY 2017

The ASM submitted funding recommendations to Congress for the Food and Drug Administration for fiscal year 2017.

ASM Urges Congressional Action on Emergency Zika Funding

The ASM sent a letter to Majority Leader McConnell and Minority Leader Reid, Speaker Ryan and Minority Leader Pelosi urging action on Zika funding legislation.

Centers for Disease Control and Prevention - FY 2017

The ASM submitted funding recommendations to Congress regarding funding for the Centers for Disease Control and Prevention for fiscal year 2017.

Payment Determinations for Calendar Year 2017 for New Clinical Laboratory Tests

The ASM presented recommendations to the Centers for Medicare & Medicaid Services (CMS) at its annual Clinical Laboratory Fee Schedule public meeting determining payment levels for new tests for 2017.

TPL_asm2013_SEARCH

137